Simplex Trading
SURF

Simplex Trading’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Simplex Trading’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,500
Closed -$18K – 10532
2022
Q4 		$18K Sell
22,500
-100
-0.4% -$99 ﹤0.01% 7007
2022
Q3 		$23K Sell
22,600
-43,400
-66% -$69.4K ﹤0.01% 7392
2022
Q2 		$108K Buy
66,000
+42,200
+177% +$87.6K ﹤0.01% 5481
2022
Q1 		$69K Buy
23,800
+17,000
+250% +$59.6K ﹤0.01% 6681
2021
Q4 		$32K Sell
6,800
-13,000
-66% -$83.9K ﹤0.01% 7834
2021
Q3 		$146K Sell
19,800
-600
-3% -$3.84K ﹤0.01% 6082
2021
Q2 		$152K Buy
20,400
+19,948
+4,413% +$154K ﹤0.01% 6116
2021
Q1 		$352K Buy
+452
New +$4.52K ﹤0.01% 3920

Simplex Trading's SURF Position: Q3 2023 in Review

Simplex Trading sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 20,332 shares — an estimated $17K sold.

Simplex Trading first reported a position in SURF in Q3 2020 and held it in 11 quarters. The position peaked at $119K in Q1 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • Simplex Trading reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 20,332 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $17K.
  • Simplex Trading first reported a position in Surface Oncology, Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Simplex Trading's Surface Oncology, Inc. Common Stock position peaked at $119K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.